30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Colucid Pharmaceuticals Inc (CLCD)

Track

Stock chart
Ticker: CLCD Exchange: NMQ
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Hogan Linda C.
Head, Bus. Dev. and Strategy
3 sales — total 58,011 USD
Planned sale 5 Jan 2017
Value US$3,892,233.55 | Price 369.90 | Shares 43,091
Planned sale 5 Jan 2017
Value US$3,340,269.74 | Price 379.10 | Shares 7,359
Planned sale 5 Jan 2017
Value US$16,005.64 | Price 33.55 | Shares 477
Planned sale 5 Jan 2017
Value US$4,193,347.89 | Price 209.92 | Shares 41,002
Planned sale 5 Jan 2017
Value US$1,523,422.65 | Price 214.05 | Shares 53,235
Planned sale 5 Jan 2017
Value US$27,465.45 | Price 34.25 | Shares 802
Planned sale 4 Jan 2017
Value US$6,734.00 | Price 36.40 | Shares 185
Planned sale 3 Jan 2017
Value US$26,027.50 | Price 36.25 | Shares 718
Planned sale 3 Jan 2017
Value US$27,985.00 | Price 36.25 | Shares 772
Planned sale 3 Jan 2017
Value US$53,396.25 | Price 36.25 | Shares 1,473
Planned sale 5 Dec 2016
Value US$58,202.50 | Price 38.75 | Shares 1,502
Planned sale 5 Dec 2016
Value US$65,022.50 | Price 38.75 | Shares 1,678
Planned sale 5 Dec 2016
Value US$7,207.50 | Price 38.75 | Shares 186
Planned sale 1 Dec 2016
Value US$25,322.53 | Price 35.22 | Shares 719
Planned sale 1 Dec 2016
Value US$27,189.99 | Price 35.22 | Shares 772
Planned sale 1 Dec 2016
Value US$51,801.14 | Price 35.17 | Shares 1,473
Planned sale 7 Nov 2016
Value US$47,830.05 | Price 28.52 | Shares 1,677
Planned sale 7 Nov 2016
Value US$42,916.95 | Price 28.57 | Shares 1,502
Planned sale 4 Nov 2016
Value US$5,355.75 | Price 28.95 | Shares 185
Planned sale 1 Nov 2016
Value US$21,570.00 | Price 30.00 | Shares 719
Planned sale 5 Oct 2016
Value US$55,694.16 | Price 37.08 | Shares 1,502
Planned sale 5 Oct 2016
Value US$62,183.16 | Price 37.08 | Shares 1,677
Planned sale 4 Oct 2016
Value US$6,735.85 | Price 36.41 | Shares 185
Planned sale 3 Oct 2016
Value US$27,135.06 | Price 37.74 | Shares 719
Planned sale 14 Sep 2016
Value US$7,134.00 | Price 23.78 | Shares 300
Planned sale 14 Sep 2016
Value US$132,812.28 | Price 23.30 | Shares 5,700
Buy 9 Sep 2016
Value US$2,000,000.00 | Price 20.00 | Shares 100,000
Planned sale 7 Sep 2016
Value US$7,319.01 | Price 24.40 | Shares 300
Planned sale 7 Sep 2016
Value US$10,354.60 | Price 23.43 | Shares 442
Planned sale 7 Sep 2016
Value US$59,548.98 | Price 22.62 | Shares 2,633
Planned sale 7 Sep 2016
Value US$21,072.13 | Price 21.90 | Shares 962
Planned sale 7 Sep 2016
Value US$13,628.30 | Price 20.56 | Shares 663
Planned sale 6 Sep 2016
Value US$29,289.00 | Price 19.50 | Shares 1,502
Planned sale 6 Sep 2016
Value US$72,832.50 | Price 19.50 | Shares 3,735
Planned sale 6 Sep 2016
Value US$628,434.56 | Price 20.00 | Shares 31,420
Planned sale 6 Sep 2016
Value US$100,640.00 | Price 20.00 | Shares 5,032
Planned sale 6 Sep 2016
Value US$166,705.50 | Price 19.50 | Shares 8,549
Planned sale 31 Aug 2016
Value US$1,629.00 | Price 10.86 | Shares 150
Planned sale 19 Aug 2016
Value US$4,272.28 | Price 8.41 | Shares 508
Planned sale 10 Aug 2016
Value US$4,216.40 | Price 8.30 | Shares 508
Planned sale 5 Aug 2016
Value US$12,481.62 | Price 8.31 | Shares 1,502
Sale 3 Aug 2016
Value US$1,051.35 | Price 8.15 | Shares 129
Sale 3 Aug 2016
Value US$660,916.10 | Price 8.15 | Shares 81,094
Sale 2 Aug 2016
Value US$278.72 | Price 8.71 | Shares 32
Sale 2 Aug 2016
Value US$171,743.78 | Price 8.71 | Shares 19,718
Sale 1 Aug 2016
Value US$740.88 | Price 8.82 | Shares 84
Sale 1 Aug 2016
Value US$460,545.12 | Price 8.82 | Shares 52,216
Planned sale 29 Jul 2016
Value US$4,615.18 | Price 9.09 | Shares 508
Planned sale 20 Jul 2016
Value US$4,556.76 | Price 8.97 | Shares 508
Planned sale 11 Jul 2016
Value US$4,622.80 | Price 9.10 | Shares 508
Planned sale 5 Jul 2016
Value US$14,614.46 | Price 9.73 | Shares 1,502
Planned sale 30 Jun 2016
Value US$3,617.68 | Price 7.01 | Shares 516
Planned sale 20 Jun 2016
Value US$3,500.00 | Price 7.00 | Shares 500
Planned sale 10 Jun 2016
Value US$3,351.99 | Price 6.60 | Shares 508
Planned sale 6 Jun 2016
Value US$10,883.94 | Price 7.25 | Shares 1,502
Sale 28 Apr 2016
Value US$1,635.60 | Price 6.96 | Shares 235
Sale 28 Apr 2016
Value US$1,042,364.40 | Price 6.96 | Shares 149,765
Buy 25 Aug 2015
Value US$53,274.75 | Price 7.10 | Shares 7,500
Buy 11 May 2015
Value US$13,000,000.00 | Price 10.00 | Shares 1,300,000
Buy 11 May 2015
Value US$5,000,000.00 | Price 10.00 | Shares 500,000
Buy 11 May 2015
Value US$175,600.00 | Price 10.00 | Shares 17,560
Buy 11 May 2015
Value US$2,824,400.00 | Price 10.00 | Shares 282,440
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2017-01-05 2017-01-05 PlS Planned sale Hogan Linda C.

Head, Bus. Dev. and Strategy
43,091 -42.3%
369.90
US$3,892,234 		43,091 -42.3% 369.90 US$3,892,234
2017-01-05 2017-01-05 PlS Planned sale Hogan Linda C.

Head, Bus. Dev. and Strategy
7,359 +15.9%
379.10
US$3,340,270 		7,359 +15.9% 379.10 US$3,340,270
2017-01-05 2017-01-05 PlS Planned sale Hogan Linda C.

Head, Bus. Dev. and Strategy
26,467 -11.5%
387.01
US$1,313,718 		26,467 -11.5% 387.01 US$1,313,718
2017-01-05 2017-01-05 PlS Planned sale Mathers Thomas P.

Chief Executive Officer

Executive Director
500 -0.2%
35.60
US$17,800 		500 -0.2% 35.60 US$17,800
2017-01-05 2017-01-05 PlS Planned sale Mathers Thomas P.

Chief Executive Officer

Executive Director
200 -0.1%
34.86
US$6,972 		200 -0.1% 34.86 US$6,972
2017-01-05 2017-01-05 PlS Planned sale Mathers Thomas P.

Chief Executive Officer

Executive Director
802 -0.3%
34.25
US$27,465 		802 -0.3% 34.25 US$27,465
2017-01-05 2017-01-04 PlS Planned sale Hogan Linda C.

Head, Bus. Dev. and Strategy
185 -100.0%
36.40
US$6,734 		185 -100.0% 36.40 US$6,734
2017-01-05 2017-01-03 PlS Planned sale Hogan Linda C.

Head, Bus. Dev. and Strategy
718 -100.0%
36.25
US$26,028 		718 -100.0% 36.25 US$26,028
2017-01-04 2017-01-03 PlS Planned sale Kuca Bernice

Head,Clin. and Reg. Operations
772 -1.9%
36.25
US$27,985 		772 -1.9% 36.25 US$27,985
2017-01-04 2017-01-03 PlS Planned sale Dallas Matthew D

Chief Financial Officer
1,473 -3.5%
36.25
US$53,396 		1,473 -3.5% 36.25 US$53,396
2016-12-05 2016-12-05 PlS Planned sale Mathers Thomas P.

Chief Executive Officer

Executive Director
1,502 -0.6%
38.75
US$58,202 		1,502 -0.6% 38.75 US$58,202
2016-12-05 2016-12-05 PlS Planned sale Hogan Linda C.

Head, Bus. Dev. and Strategy

Officer
1,678 -100.0%
38.75
US$65,022 		1,678 -100.0% 38.75 US$65,022
2016-12-05 2016-12-05 PlS Planned sale Hogan Linda C.

Head, Bus. Dev. and Strategy

Officer
186 -100.0%
38.75
US$7,208 		186 -100.0% 38.75 US$7,208
2016-12-05 2016-12-01 PlS Planned sale Hogan Linda C.

Head, Bus. Dev. and Strategy

Officer
719 -100.0%
35.22
US$25,323 		719 -100.0% 35.22 US$25,323
2016-12-01 2016-12-01 PlS Planned sale Kuca Bernice

Head,Clin. and Reg. Operations

Officer
772 -1.9%
35.22
US$27,190 		772 -1.9% 35.22 US$27,190
2016-12-01 2016-12-01 PlS Planned sale Dallas Matthew D

Chief Financial Officer

Officer
1,473 -3.4%
35.17
US$51,801 		1,473 -3.4% 35.17 US$51,801
2016-11-07 2016-11-07 PlS Planned sale Hogan Linda C.

Head, Bus. Dev. and Strategy

Officer
1,677 -100.0%
28.52
US$47,830 		1,677 -100.0% 28.52 US$47,830
2016-11-07 2016-11-07 PlS Planned sale Mathers Thomas P.

Chief Executive Officer

Executive Director
1,502 -0.6%
28.57
US$42,917 		1,502 -0.6% 28.57 US$42,917
2016-11-07 2016-11-04 PlS Planned sale Hogan Linda C.

Head, Bus. Dev. and Strategy

Officer
185 -100.0%
28.95
US$5,356 		185 -100.0% 28.95 US$5,356
2016-11-01 2016-11-01 PlS Planned sale Hogan Linda C.

Head, Bus. Dev. and Strategy

Officer
719 -100.0%
30.00
US$21,570 		719 -100.0% 30.00 US$21,570
2016-10-05 2016-10-05 PlS Planned sale Mathers Thomas P.

Chief Executive Officer

Executive Director
1,502 -0.6%
37.08
US$55,694 		1,502 -0.6% 37.08 US$55,694
2016-10-05 2016-10-05 PlS Planned sale Hogan Linda C.

Head, Bus. Dev. and Strategy

Officer
1,677 -100.0%
37.08
US$62,183 		1,677 -100.0% 37.08 US$62,183
2016-10-05 2016-10-04 PlS Planned sale Hogan Linda C.

Head, Bus. Dev. and Strategy

Officer
185 -100.0%
36.41
US$6,736 		185 -100.0% 36.41 US$6,736
2016-10-05 2016-10-03 PlS Planned sale Hogan Linda C.

Head, Bus. Dev. and Strategy

Officer
719 -100.0%
37.74
US$27,135 		719 -100.0% 37.74 US$27,135
2016-09-16 2016-09-14 PlS Planned sale Mathers Thomas P.

Chief Executive Officer

Executive Director
300 -0.1%
23.78
US$7,134 		300 -0.1% 23.78 US$7,134
2016-09-16 2016-09-14 PlS Planned sale Mathers Thomas P.

Chief Executive Officer

Executive Director
5,700 -2.3%
23.30
US$132,812 		5,700 -2.3% 23.30 US$132,812
2016-09-13 2016-09-09 B Purchase Novo A/S Large shareholder
100,000 +3.3%
20.00
US$2,000,000 		100,000 +3.3% 20.00 US$2,000,000
2016-09-07 2016-09-07 PlS Planned sale Mathers Thomas P.

Chief Executive Officer

Executive Director
300 -0.1%
24.40
US$7,319 		300 -0.1% 24.40 US$7,319
2016-09-07 2016-09-07 PlS Planned sale Mathers Thomas P.

Chief Executive Officer

Executive Director
442 -0.2%
23.43
US$10,355 		442 -0.2% 23.43 US$10,355
2016-09-07 2016-09-07 PlS Planned sale Mathers Thomas P.

Chief Executive Officer

Executive Director
2,633 -1.0%
22.62
US$59,549 		2,633 -1.0% 22.62 US$59,549
2016-09-07 2016-09-07 PlS Planned sale Mathers Thomas P.

Chief Executive Officer

Executive Director
962 -0.4%
21.90
US$21,072 		962 -0.4% 21.90 US$21,072
2016-09-07 2016-09-07 PlS Planned sale Mathers Thomas P.

Chief Executive Officer

Executive Director
663 -0.3%
20.56
US$13,628 		663 -0.3% 20.56 US$13,628
2016-09-07 2016-09-06 PlS Planned sale Mathers Thomas P.

Chief Executive Officer

Executive Director
1,502 -0.6%
19.50
US$29,289 		1,502 -0.6% 19.50 US$29,289
2016-09-07 2016-09-06 PlS Planned sale Hogan Linda C.

Head, Bus. Dev. and Strategy

Officer
3,735 -100.0%
19.50
US$72,832 		3,735 -100.0% 19.50 US$72,832
2016-09-07 2016-09-06 PlS Planned sale Hogan Linda C.

Head, Bus. Dev. and Strategy

Officer
31,420 -100.0%
20.00
US$628,435 		31,420 -100.0% 20.00 US$628,435
2016-09-07 2016-09-06 PlS Planned sale Hogan Linda C.

Head, Bus. Dev. and Strategy

Officer
5,032 -13.8%
20.00
US$100,640 		5,032 -13.8% 20.00 US$100,640
2016-09-07 2016-09-06 PlS Planned sale Hogan Linda C.

Head, Bus. Dev. and Strategy

Officer
8,549 -19.0%
19.50
US$166,706 		8,549 -19.0% 19.50 US$166,706
2016-08-31 2016-08-31 PlS Planned sale Skwierczynski Raymond

Head,Pharmaceutical Operations

Officer
150 -76.1%
10.86
US$1,629 		150 -76.1% 10.86 US$1,629
2016-08-19 2016-08-19 PlS Planned sale Skwierczynski Raymond

Head,Pharmaceutical Operations

Officer
508 -72.1%
8.41
US$4,272 		508 -72.1% 8.41 US$4,272
2016-08-10 2016-08-10 PlS Planned sale Skwierczynski Raymond

Head,Pharmaceutical Operations

Officer
508 -41.9%
8.30
US$4,216 		508 -41.9% 8.30 US$4,216
2016-08-05 2016-08-05 PlS Planned sale Mathers Thomas P.

Chief Executive Officer

Executive Director
1,502 -0.6%
8.31
US$12,482 		1,502 -0.6% 8.31 US$12,482
2016-08-03 2016-08-03 S Sale DP VI Associates, L.P. Large shareholder
129 -4.1%
8.15
US$1,051 		129 -4.1% 8.15 US$1,051
2016-08-03 2016-08-03 S Sale Domain Partners VI, L.P. Large shareholder
81,094 -4.0%
8.15
US$660,916 		81,094 -4.0% 8.15 US$660,916
2016-08-03 2016-08-02 S Sale DP VI Associates, L.P. Large shareholder
32 -1.0%
8.71
US$279 		32 -1.0% 8.71 US$279
2016-08-03 2016-08-02 S Sale Domain Partners VI, L.P. Large shareholder
19,718 -1.0%
8.71
US$171,744 		19,718 -1.0% 8.71 US$171,744
2016-08-03 2016-08-01 S Sale DP VI Associates, L.P. Large shareholder
84 -2.6%
8.82
US$741 		84 -2.6% 8.82 US$741
2016-08-03 2016-08-01 S Sale Domain Partners VI, L.P. Large shareholder
52,216 -2.5%
8.82
US$460,545 		52,216 -2.5% 8.82 US$460,545
2016-07-29 2016-07-29 PlS Planned sale Skwierczynski Raymond

Head,Pharmaceutical Operations

Officer
508 -29.5%
9.09
US$4,615 		508 -29.5% 9.09 US$4,615
2016-07-20 2016-07-20 PlS Planned sale Skwierczynski Raymond

Head,Pharmaceutical Operations

Officer
508 -22.8%
8.97
US$4,557 		508 -22.8% 8.97 US$4,557
2016-07-12 2016-07-11 PlS Planned sale Skwierczynski Raymond

Head,Pharmaceutical Operations

Officer
508 -18.6%
9.10
US$4,623 		508 -18.6% 9.10 US$4,623
2016-07-05 2016-07-05 PlS Planned sale Mathers Thomas P.

Chief Executive Officer

Executive Director
1,502 -0.6%
9.73
US$14,614 		1,502 -0.6% 9.73 US$14,614
2016-06-30 2016-06-30 PlS Planned sale Skwierczynski Raymond

Head,Pharmaceutical Operations

Officer
516 -15.9%
7.01
US$3,618 		516 -15.9% 7.01 US$3,618
2016-06-22 2016-06-20 PlS Planned sale Skwierczynski Raymond

Head,Pharmaceutical Operations

Officer
500 -13.3%
7.00
US$3,500 		500 -13.3% 7.00 US$3,500
2016-06-22 2016-06-10 PlS Planned sale Skwierczynski Raymond

Head,Pharmaceutical Operations

Officer
508 -11.9%
6.60
US$3,352 		508 -11.9% 6.60 US$3,352
2016-06-07 2016-06-06 PlS Planned sale Mathers Thomas P.

Chief Executive Officer

Executive Director
1,502 -0.6%
7.25
US$10,884 		1,502 -0.6% 7.25 US$10,884
2016-05-02 2016-04-28 S Sale DP VI Associates, L.P. Large shareholder
235 -6.7%
6.96
US$1,636 		235 -6.7% 6.96 US$1,636
2016-05-02 2016-04-28 S Sale Domain Partners VI, L.P. Large shareholder
149,765 -6.7%
6.96
US$1,042,364 		149,765 -6.7% 6.96 US$1,042,364
2015-08-25 2015-08-25 B Purchase Mathers Thomas P.

Chief Executive Officer

Executive Director
7,500 +inf%
7.10
US$53,275 		7,500 +inf% 7.10 US$53,275
2015-05-12 2015-05-11 B Purchase Novo A/S Large shareholder
1,300,000 +74.0%
10.00
US$13,000,000 		1,300,000 +74.0% 10.00 US$13,000,000
2015-05-12 2015-05-11 B Purchase Marengere Luc Non-Executive Director Large shareholder
500,000 +50.2%
10.00
US$5,000,000 		500,000 +50.2% 10.00 US$5,000,000
2015-05-12 2015-05-11 B Purchase PAPPAS ARTHUR M Non-Executive Director Large shareholder
17,560 +17.8%
10.00
US$175,600 		17,560 +17.8% 10.00 US$175,600
2015-05-12 2015-05-11 B Purchase PAPPAS ARTHUR M Non-Executive Director Large shareholder
282,440 +17.8%
10.00
US$2,824,400 		282,440 +17.8% 10.00 US$2,824,400
Explore more

More insider trading research around Colucid Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America